Bovista
NDC 63545-535, Bovista, pellet, from Hahnemann Laboratories, INC..
- Product NDC
- 63545-535
- Status
- Listed
- Labeler
- Hahnemann Laboratories, INC.
- Dosage form
- PELLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63545-535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LYCOPERDON UTRIFORME FRUITING BODY30 [hp_C]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63545-535-01 | 63545053501 | 80 PELLET in 1 VIAL, GLASS (63545-535-01) |
| 63545-535-02 | 63545053502 | 200 PELLET in 1 VIAL, GLASS (63545-535-02) |
| 63545-535-03 | 63545053503 | 1200 PELLET in 1 BOTTLE, GLASS (63545-535-03) |
| 63545-535-04 | 63545053504 | 4000 PELLET in 1 BOTTLE, GLASS (63545-535-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63545-535 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63545-535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63545-535. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.